Tag | Content |
---|
EnhancerAtlas ID | HS018-23827 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr9:96056860-96058260 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ZEB1 | MA0103.3 | chr9:96057043-96057054 | GGGCAGGTGGG | - | 6.14 | ZNF263 | MA0528.1 | chr9:96058008-96058029 | CCTTCCTCCCCCACCTTCCTC | - | 6.04 | ZNF263 | MA0528.1 | chr9:96058124-96058145 | CTCCTCTCTCCATCCTCCCCT | - | 6.07 | ZNF263 | MA0528.1 | chr9:96058236-96058257 | CTCCTCTCTCCATCCTCCCCT | - | 6.07 | ZNF263 | MA0528.1 | chr9:96058037-96058058 | ATCCTCCCCTCTCCATCCTCC | - | 6.12 | ZNF263 | MA0528.1 | chr9:96058023-96058044 | TTCCTCCCCTCTCTATCCTCC | - | 6.14 | ZNF263 | MA0528.1 | chr9:96058093-96058114 | TTCCTCCCCTCTCCATCCTCA | - | 6.14 | ZNF263 | MA0528.1 | chr9:96058149-96058170 | TTCCTCCCCTCTCCATCCTCA | - | 6.14 | ZNF263 | MA0528.1 | chr9:96058026-96058047 | CTCCCCTCTCTATCCTCCCCT | - | 6.15 | ZNF263 | MA0528.1 | chr9:96058005-96058026 | TCACCTTCCTCCCCCACCTTC | - | 6.1 | ZNF263 | MA0528.1 | chr9:96058194-96058215 | CTCCCCTCACTTTCCTCCCCT | - | 6.25 | ZNF263 | MA0528.1 | chr9:96058040-96058061 | CTCCCCTCTCCATCCTCCCTT | - | 6.28 | ZNF263 | MA0528.1 | chr9:96058082-96058103 | TTCCCCTCACTTTCCTCCCCT | - | 6.33 | ZNF263 | MA0528.1 | chr9:96057968-96057989 | ATCCTCTCCTCTCCATCCTCC | - | 6.36 | ZNF263 | MA0528.1 | chr9:96058009-96058030 | CTTCCTCCCCCACCTTCCTCC | - | 6.36 | ZNF263 | MA0528.1 | chr9:96058012-96058033 | CCTCCCCCACCTTCCTCCCCT | - | 6.73 | ZNF263 | MA0528.1 | chr9:96058121-96058142 | TTCCTCCTCTCTCCATCCTCC | - | 6.74 | ZNF263 | MA0528.1 | chr9:96058233-96058254 | TTCCTCCTCTCTCCATCCTCC | - | 6.74 | ZNF263 | MA0528.1 | chr9:96058138-96058159 | CTCCCCTCACCTTCCTCCCCT | - | 6.82 | ZNF263 | MA0528.1 | chr9:96057999-96058020 | CTCCCCTCACCTTCCTCCCCC | - | 7.7 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_58427 | chr9:96005910-96065426 | Ly1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr9 | 96057122 | 96057472 | chr9 | 96058014 | 96058094 | chr9 | 96057493 | 96057765 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH09I093294 | chr9 | 96057122 | 96057472 | GH09I093295 | chr9 | 96057493 | 96057765 |
|
Enhancer Sequence | CACCCCAGCT GTGGCTGCTA CGAAGAGAAG CTTGTAGGGG GCAGGAAGGT GTGGATGTGA 60 GAACACTGGG GAGAGGAGCT GCTATAGGCT CTGAGAGCCT GGGTGACAGG GGCCAGGAGC 120 CAGAGACAGA GGGTAGAGAT AATGGGGTGG GGACTAGAAA TGGCAGAAGT GATTGGGAGC 180 CAGGGGCAGG TGGGGTCTAG GGAAAGGGCA GGGAGAGGAC CAGAAGCACC TCAAAGGAGA 240 GACTTCCAGG AGCCTAAGAA CAGGAAGTGG ATGCTGGGAG GGCCGTGGAG TCCAGAGGGA 300 AGTGTGGGGA CCTTTTAGGA AAGGGTGGGG AAGATTTTCA GCCTCAACTG GGAATTGAGG 360 TGACTTGGCA TCTGATAGGC AGTAGCCAGC AGCTCCCCAA CCTTGCTTTC ATTTGAACCC 420 TCTGAATACC GAGGTGCCTG TGCCTCATTG CAGCATTTCT GCCATGAGCG TTGGGGTTTC 480 CTAGGGCTCC AGGAGCCCTG TGCTGAGCCC AGCCTGTGCT TTCAGATGTC CCAGGCCGCG 540 GGGCTCTGTG GTGAGCAGCC CAGGGGCAGC TTGGAGTGGT CCAGGGCACC CCCTGTGTCG 600 GAGCCACATT GCAGTCTGGG ACCGCGGGAG CTGGACCATG TGGGTGCGGC CTCGGAGCAG 660 AGTTCCAACC TGGATAAGCT CCAGCCTGGA TAAGACGCTC CCCTGCCCAC GCAGCCGCTC 720 CCCAACGCTG GGGCAGTCAG CACTCTCTTG AAATAGTACT CCCTTCCAGA AGATCATCTG 780 ATGCTCTGTC TCTCTGGTGT TTGTAGGGAG AAAGCCATTC AGAGTTTTAT TTTTATTTAT 840 TTATTTTGTT TAGTAGTTAG AGGAAGTCAT TAAAAAAAAA CAAAAAGCCT ATGTGGCAGG 900 TGTTGAAATT CAGGAGTAAA ATCAGAACTT GCTTCCTCAT TTCCGACCTT GAAAACTACC 960 TGTTTTTCTT GCCATCAAAG GAAGAGGAGG GGCACTTGGG GTGAAGGCAA GGGGTTACAG 1020 GCCTCCAGCC AGGGCCCCTG GGGTGGCCTT AGGCCTTGCA GAAGCTCAGA GCACTGTGAT 1080 GCAACAGGGA GGCCCAGCTC CACTCCCCAT CCTCTCCTCT CCATCCTCCC GTCACCATCC 1140 TCCCCTCACC TTCCTCCCCC ACCTTCCTCC CCTCTCTATC CTCCCCTCTC CATCCTCCCT 1200 TCACCTTCCT TGTCTCTCCA GCTTCCCCTC ACTTTCCTCC CCTCTCCATC CTCAACTCAC 1260 TTTCCTCCTC TCTCCATCCT CCCCTCACCT TCCTCCCCTC TCCATCCTCA ACTCACTTTC 1320 CTCCTCTCTC CAACCTCCCC TCACTTTCCT CCCCTCTCCA CCCTCAACTC ACTTTCCTCC 1380 TCTCTCCATC CTCCCCTCAC 1400
|